Related Experiment Video

Updated: May 9, 2026

The Logic, Experimental Steps, and Potential of Heterologous Natural Product Biosynthesis Featuring the Complex Antibiotic Erythromycin A Produced Through E. coli
10:41

The Logic, Experimental Steps, and Potential of Heterologous Natural Product Biosynthesis Featuring the Complex Antibiotic Erythromycin A Produced Through E. coli

Published on: January 13, 2013

Teichoic acid biosynthesis as an antibiotic target

Lincoln W Pasquina1, John P Santa Maria, Suzanne Walker

  • 1Department of Microbiology and Immunobiology, Harvard Medical School, Boston, MA 02115, United States.

Current Opinion in Microbiology
|August 7, 2013
PubMed

Insights

New antibiotics targeting bacterial cell wall polymers like lipoteichoic acids (LTAs) and wall teichoic acids (WTAs) are crucial for combating antibiotic-resistant pathogens, particularly Staphylococcus aureus.

Area of Science:

  • Microbiology
  • Bacterial Pathogenesis
  • Drug Discovery

Background:

  • Antibiotic resistance is a growing global health threat.
  • Bacterial cell wall components are essential for pathogen survival and virulence.
  • Lipoteichoic acids (LTAs) and wall teichoic acids (WTAs) are key Gram-positive cell wall polymers and potential drug targets.

Purpose of the Study:

  • To explore teichoic acid biosynthesis as a novel target for antibiotic development.
  • To report recent advancements in discovering inhibitors of teichoic acid synthesis.
  • To evaluate the potential of these inhibitors as new antibiotics against Staphylococcus aureus.

Main Methods:

  • Investigated pathways involved in LTA and WTA biosynthesis.
  • Screened for small molecules inhibiting teichoic acid synthesis.
  • Assessed the efficacy of identified inhibitors against Staphylococcus aureus.

Main Results:

  • Identified key enzymes and pathways in teichoic acid biosynthesis.
  • Discovered novel inhibitors targeting these pathways.
  • Demonstrated the potential of these inhibitors to combat Staphylococcus aureus infections.

Conclusions:

  • Teichoic acid biosynthesis represents a promising target for novel antibiotic development.
  • Inhibitors of teichoic acid synthesis show potential for treating infections caused by antibiotic-resistant Gram-positive bacteria.
  • Further development of these compounds could lead to new therapeutic strategies against Staphylococcus aureus.

More Related Videos

Synthesis of Masarimycin, a Small Molecule Inhibitor of Gram-Positive Bacterial Growth09:10

Synthesis of Masarimycin, a Small Molecule Inhibitor of Gram-Positive Bacterial Growth

Published on: January 7, 2022

Antimicrobial Peptides Produced by Selective Pressure Incorporation of Non-canonical Amino Acids11:56

Antimicrobial Peptides Produced by Selective Pressure Incorporation of Non-canonical Amino Acids

Published on: May 4, 2018

Related Concept Videos

Inhibitors of Gram-positive Cell Wall Synthesis01:23

Inhibitors of Gram-positive Cell Wall Synthesis

Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...
Formation of Lipopolysaccharides01:19

Formation of Lipopolysaccharides

Lipopolysaccharides (LPS) are crucial components of the outer membrane of Gram-negative bacteria, serving both structural and functional roles. It contributes to membrane stability and protects bacteria from host immune responses. LPS is composed of three major regions—lipid A, a core oligosaccharide, and an O antigen. The biosynthesis and assembly of LPS involve a highly coordinated set of enzymatic reactions and transport mechanisms. Additionally, LPS is recognized as an endotoxin, triggering...
Inhibitors of Bacterial Protein Synthesis01:25

Inhibitors of Bacterial Protein Synthesis

Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...
Production of Antibiotics01:27

Production of Antibiotics

Penicillin, one of the earliest and most widely used antibiotics, is produced industrially by the filamentous fungus Penicillium chrysogenum. Large stirred-tank bioreactors ranging from tens to hundreds of thousands of liters maintain tightly controlled temperature, pH, and dissolved oxygen conditions to support fungal metabolism and maximize antibiotic yield. Penicillin is a secondary metabolite, synthesized primarily during the stationary growth phase, which requires a carefully managed...
Peptidoglycan Synthesis01:28

Peptidoglycan Synthesis

Structure of PeptidoglycanPeptidoglycan is a vital structural component of the bacterial cell wall, providing mechanical strength and shape to the cell. It consists of repeating units of two sugars—N-acetylglucosamine (NAG) and N-acetylmuramic acid (NAM)—linked by β-1,4 glycosidic bonds. These sugar chains are cross-linked by short peptide chains, forming a mesh-like polymer that surrounds the bacterial plasma membrane.Cytoplasmic Phase – Precursor SynthesisPeptidoglycan biosynthesis begins in...
Biosynthesis in Bacteria01:24

Biosynthesis in Bacteria

Biosynthesis in bacteria is a fundamental anabolic process that generates essential macromolecules, including proteins, nucleic acids, lipids, and polysaccharides. These macromolecules are critical for cellular growth, replication, and function. The process is tightly regulated and energetically linked to catabolic pathways to ensure optimal resource utilization.Biosynthetic pathways begin with precursor metabolites such as pyruvate, acetyl-CoA, and glucose-6-phosphate derived from glycolysis,...